查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379128

按應用分類的吸入一氧化氮市場報告（新生兒呼吸治療、慢性阻塞性肺病 (COPD)、急性呼吸窘迫症候群 (ARDS) 等）和地區 2023-2028

Inhaled Nitric Oxide Market Report by Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), and Others), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球吸入一氧化氮市場規模達8.77億美元。展望未來， IMARC Group預計到2028年市場規模將達到13.611億美元，2022-2028年複合年成長率（CAGR）為7.6%。

吸入一氧化氮 (iNO) 是一種選擇性肺血管擴張劑，由三級新生兒加護病房 (NICU) 熟練醫生監督。它透過改善通氣-灌注不匹配和降低肺血管阻力升高和高血壓，有助於調節血管肌張力並治療新生兒低氧性呼吸衰竭。它還有助於改善氧合併減少對體外膜氧合（ECMO）的需求。目前，擴大使用 iNO 療法作為急性呼吸窘迫症候群 (ARDS) 患者的救援藥物。

吸入一氧化氮市場趨勢：

新生兒呼吸系統疾病和其他後續疾病（例如持續性肺動脈高壓和新生兒缺氧性呼吸衰竭（HRF））的盛行率不斷增加，是顯著促進市場成長的主要因素之一。此外，相對更容易患高血壓、動脈粥狀硬化、週邊動脈疾病、心臟衰竭和血栓形成的老年人口不斷增加，也支持了市場的成長。此外，iNO 在治療慢性阻塞性肺病 (COPD)、氣喘和 ARDS 方面在全球範圍內獲得了巨大的關注。此外，高度傳染性的冠狀病毒疾病（COVID-19）的爆發以及全球範圍內感染人數的驚人增加正在對市場產生有利的影響。此外，iNO 療法也用於對抗冠狀病毒感染，因為它有助於改善重症肺炎患者的通氣/灌注。該市場也受到世界各地醫療保健行業正在進行的研究和開發（R＆D）活動的​​推動，以改善整體患者體驗。

本報告回答的關鍵問題：

  • 迄今為止，全球吸入一氧化氮市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球吸入一氧化氮市場有何影響？
  • 主要區域市場有哪些？
  • 基於應用程式的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球吸入一氧化氮市場的結構如何？誰是主要參與者？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球吸入一氧化氮市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按應用分類的市場區隔

  • 新生兒呼吸治療
    • 市場走向
    • 市場預測
  • 慢性阻塞性肺病（COPD）
    • 市場走向
    • 市場預測
  • 急性呼吸窘迫症候群（ARDS）
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 8 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 9 章：價值鏈分析

第 10 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 11 章：價格分析

第 12 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Air Liquide SA
    • Bellerophon Therapeutics
    • Beyond Air Inc.
    • Linde plc
    • Mallinckrodt plc
    • Merck KGaA
    • Novoteris LLC
    • Nu-Med Plus
    • VERO Biotech LLC
Product Code: SR112023A4100

Abstract

The global inhaled nitric oxide market size reached US$ 877.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,361.1 Million by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2022-2028.

Inhaled nitric oxide (iNO) refers to a selective pulmonary vasodilator supervised by skilled physicians at tertiary neonatal intensive care units (NICUs). It assists in regulating vascular muscle tone and treating hypoxemic respiratory failure among newly born infants by improving ventilation-perfusion mismatch and reducing elevated pulmonary vascular resistance and hypertension. It also aids in improving oxygenation and decreasing the need for extracorporeal membrane oxygenation (ECMO). At present, there is a rise in the use of iNO therapy as a rescue agent for acute respiratory distress syndrome (ARDS) patients.

Inhaled Nitric Oxide Market Trends:

The increasing prevalence of respiratory and other subsequent diseases in newborns, such as persistent pulmonary hypertension and neonatal hypoxic respiratory failure (HRF), represents one of the primary factors significantly contributing to the market growth. Additionally, the rising geriatric population, which is relatively more prone to hypertension, atherosclerosis, peripheral artery disease, heart failure, and thrombosis, is supporting the growth of the market. Furthermore, iNO is gaining immense traction worldwide for treating chronic obstructive pulmonary diseases (COPD), asthma, and ARDS. Moreover, the outbreak of the highly contagious coronavirus disease (COVID-19) and an alarmingly increasing number of individuals getting infected on a global level are favorably influencing the market. Furthermore, iNO therapy is being used against coronavirus stains as it assists in improving ventilation/perfusion in patients with severe pneumonia. The market is also driven by the ongoing research and development (R&D) activities in the healthcare industry around the world to improve the overall patient experience.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global inhaled nitric oxide market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on application.

Breakup by Application:

Neonatal Respiratory Treatment

Chronic Obstructive Pulmonary Disease (COPD)

Acute Respiratory Distress Syndrome (ARDS)

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Air Liquide S.A, Bellerophon Therapeutics, Beyond Air Inc., Linde plc, Mallinckrodt plc, Merck KGaA, Novoteris LLC, Nu-Med Plus and VERO Biotech LLC.

Key Questions Answered in This Report:

  • How has the global inhaled nitric oxide market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global inhaled nitric oxide market?
  • What are the key regional markets?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global inhaled nitric oxide market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Inhaled Nitric Oxide Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Neonatal Respiratory Treatment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Acute Respiratory Distress Syndrome (ARDS)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Region

  • 7.1 North America
    • 7.1.1 United States
      • 7.1.1.1 Market Trends
      • 7.1.1.2 Market Forecast
    • 7.1.2 Canada
      • 7.1.2.1 Market Trends
      • 7.1.2.2 Market Forecast
  • 7.2 Asia-Pacific
    • 7.2.1 China
      • 7.2.1.1 Market Trends
      • 7.2.1.2 Market Forecast
    • 7.2.2 Japan
      • 7.2.2.1 Market Trends
      • 7.2.2.2 Market Forecast
    • 7.2.3 India
      • 7.2.3.1 Market Trends
      • 7.2.3.2 Market Forecast
    • 7.2.4 South Korea
      • 7.2.4.1 Market Trends
      • 7.2.4.2 Market Forecast
    • 7.2.5 Australia
      • 7.2.5.1 Market Trends
      • 7.2.5.2 Market Forecast
    • 7.2.6 Indonesia
      • 7.2.6.1 Market Trends
      • 7.2.6.2 Market Forecast
    • 7.2.7 Others
      • 7.2.7.1 Market Trends
      • 7.2.7.2 Market Forecast
  • 7.3 Europe
    • 7.3.1 Germany
      • 7.3.1.1 Market Trends
      • 7.3.1.2 Market Forecast
    • 7.3.2 France
      • 7.3.2.1 Market Trends
      • 7.3.2.2 Market Forecast
    • 7.3.3 United Kingdom
      • 7.3.3.1 Market Trends
      • 7.3.3.2 Market Forecast
    • 7.3.4 Italy
      • 7.3.4.1 Market Trends
      • 7.3.4.2 Market Forecast
    • 7.3.5 Spain
      • 7.3.5.1 Market Trends
      • 7.3.5.2 Market Forecast
    • 7.3.6 Russia
      • 7.3.6.1 Market Trends
      • 7.3.6.2 Market Forecast
    • 7.3.7 Others
      • 7.3.7.1 Market Trends
      • 7.3.7.2 Market Forecast
  • 7.4 Latin America
    • 7.4.1 Brazil
      • 7.4.1.1 Market Trends
      • 7.4.1.2 Market Forecast
    • 7.4.2 Mexico
      • 7.4.2.1 Market Trends
      • 7.4.2.2 Market Forecast
    • 7.4.3 Others
      • 7.4.3.1 Market Trends
      • 7.4.3.2 Market Forecast
  • 7.5 Middle East and Africa
    • 7.5.1 Market Trends
    • 7.5.2 Market Breakup by Country
    • 7.5.3 Market Forecast

8 SWOT Analysis

  • 8.1 Overview
  • 8.2 Strengths
  • 8.3 Weaknesses
  • 8.4 Opportunities
  • 8.5 Threats

9 Value Chain Analysis

10 Porters Five Forces Analysis

  • 10.1 Overview
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Degree of Competition
  • 10.5 Threat of New Entrants
  • 10.6 Threat of Substitutes

11 Price Analysis

12 Competitive Landscape

  • 12.1 Market Structure
  • 12.2 Key Players
  • 12.3 Profiles of Key Players
    • 12.3.1 Air Liquide S.A
      • 12.3.1.1 Company Overview
      • 12.3.1.2 Product Portfolio
      • 12.3.1.3 Financials
      • 12.3.1.4 SWOT Analysis
    • 12.3.2 Bellerophon Therapeutics
      • 12.3.2.1 Company Overview
      • 12.3.2.2 Product Portfolio
      • 12.3.2.3 Financials
    • 12.3.3 Beyond Air Inc.
      • 12.3.3.1 Company Overview
      • 12.3.3.2 Product Portfolio
      • 12.3.3.3 Financials
    • 12.3.4 Linde plc
      • 12.3.4.1 Company Overview
      • 12.3.4.2 Product Portfolio
      • 12.3.4.3 Financials
    • 12.3.5 Mallinckrodt plc
      • 12.3.5.1 Company Overview
      • 12.3.5.2 Product Portfolio
      • 12.3.5.3 Financials
    • 12.3.6 Merck KGaA
      • 12.3.6.1 Company Overview
      • 12.3.6.2 Product Portfolio
      • 12.3.6.3 Financials
      • 12.3.6.4 SWOT Analysis
    • 12.3.7 Novoteris LLC
      • 12.3.7.1 Company Overview
      • 12.3.7.2 Product Portfolio
    • 12.3.8 Nu-Med Plus
      • 12.3.8.1 Company Overview
      • 12.3.8.2 Product Portfolio
      • 12.3.8.3 Financials
    • 12.3.9 VERO Biotech LLC
      • 12.3.9.1 Company Overview
      • 12.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Inhaled Nitric Oxide Market: Major Drivers and Challenges
  • Figure 2: Global: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Inhaled Nitric Oxide Market: Breakup by Application (in %), 2022
  • Figure 5: Global: Inhaled Nitric Oxide Market: Breakup by Region (in %), 2022
  • Figure 6: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 7: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 8: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome (ARDS)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome (ARDS)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Inhaled Nitric Oxide (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Inhaled Nitric Oxide (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: North America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: North America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: United States: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: United States: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Canada: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Canada: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Asia-Pacific: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Asia-Pacific: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: China: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: China: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Japan: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Japan: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: India: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: India: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: South Korea: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: South Korea: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Australia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Australia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Indonesia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Indonesia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Europe: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Europe: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Germany: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Germany: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: France: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: France: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United Kingdom: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United Kingdom: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Italy: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Italy: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Spain: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Spain: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Russia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Russia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Latin America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Latin America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Brazil: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Brazil: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Mexico: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Mexico: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Middle East and Africa: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Middle East and Africa: Inhaled Nitric Oxide Market: Breakup by Country (in %), 2022
  • Figure 62: Middle East and Africa: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Global: Inhaled Nitric Oxide Industry: SWOT Analysis
  • Figure 64: Global: Inhaled Nitric Oxide Industry: Value Chain Analysis
  • Figure 65: Global: Inhaled Nitric Oxide Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Inhaled Nitric Oxide Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Inhaled Nitric Oxide Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 3: Global: Inhaled Nitric Oxide Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 4: Global: Inhaled Nitric Oxide Market: Competitive Structure
  • Table 5: Global: Inhaled Nitric Oxide Market: Key Players